(Q39947963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

review article

1 reference

title

Individualization of propranolol therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

author name string

D G Shand

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 September 1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

30 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

1063-1069

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Metabolism of propranolol ('Inderal'), a potent, specific beta-adrenergic receptor blocking agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Multicenter trial of propranolol in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Central Hypotensive Activity of dl- and d-Propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Mechanism of Beta-Blockade Hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Propranolol Dose Determinants Including Blood Level Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Minoxidil--an alternative to nephrectomy for refractory hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Plasma propranolol levels in adults With observations in four children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

The disposition of propranolol. I. Elimination during oral absorption in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Hypertrophic obstructive cardiomyopathy in an infant--propranolol therapy for three years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Relation of propranolol plasma level to beta-blockade during oral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Propranolol in hypertension: a study of long-term therapy, 1964-1970

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2932102-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(16)32102-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4609366%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference